Generic Pharmaceutical Market: Digital Pharma Innovation, Biosimilars Expansion & Cost-Effective Healthcare Solutions (2025–2033) Written By Shubham Senior Pharmaceutical & Healthcare Technology Market Research Analyst | M2Square ConsultancyExperience: 4+ Years Shubham is a healthcare and pharmaceutical industry analyst specializing in generic medicines, biosimilars, digital...

Market Overview The sterile injectable contract manufacturing market was valued at USD 24.15 billion in 2025 and is projected to reach USD 68.05 billion by 2034, growing at a CAGR of 12.2% from 2026 to 2034, according to Polaris Market Research. The report finds that sponsors are looking to external partners for specialized sterile capabilities as drug pipelines become more complex, and it...

The Biopharmaceuticals Contract Manufacturing Market is expanding as pharmaceutical and biotechnology companies increasingly outsource complex biologics manufacturing to specialized contract development and manufacturing organizations. The market was valued at USD 44.7 billion in 2025 and is projected to grow from USD 50.0 billion in 2026 to USD 100.8 billion by 2033, registering a CAGR of...